Presenter: Michael Gazda, Ph.D. The abstracts are scheduled to be posted to the ASCO GI Online Program at 5 PM ET on Monday, January 6. About BXQ-350 Bexion's lead drug candidate is BXQ-350, a ...
Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides derived from Protagonist's proprietary discovery platform are currently in advanced ...
The Python Software Foundation has rejected a $1.5 million government grant because of anti-DEI requirements imposed by the Trump administration, the nonprofit said in a blog post yesterday. The grant ...
Create foundational programming structures with Python. The Python programming language was developed to provide a way to develop code that's easy to create and understand. While Python contains the ...
SAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class WEE1 inhibitor for ...
Creating simple data classes in Java traditionally required substantial boilerplate code. Consider how we would represent Java’s mascots, Duke and Juggy: public class JavaMascot { private final String ...
Welcome to the official repository for Introduction to GIS Programming: A Practical Python Guide to Open Source Geospatial Tools. This repository contains all the code examples featured in the book, ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Programming is a key transferable skill within the chemical sciences with applications ...
TIOBE Programming Index News August 2025: AI Copilots Are Boosting Python’s Popularity Your email has been sent Generative AI can be a self-fulfilling prophecy: Because gen AI scans vast amounts of ...
Python maintains its runaway top ranking in the Tiobe index of programming language popularity, while older languages continue to rise. Perl surprises. Python, the highest-ranking language ever in the ...
PHILADELPHIA and VANCOUVER, British Columbia, July 25, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (BCTX) (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT ...